TR201905632T4 - Bir tümörün tedavisinde kullanıma yönelik preeklamptik plasental mezenkimal kök hücre koşullu ortam. - Google Patents
Bir tümörün tedavisinde kullanıma yönelik preeklamptik plasental mezenkimal kök hücre koşullu ortam. Download PDFInfo
- Publication number
- TR201905632T4 TR201905632T4 TR2019/05632T TR201905632T TR201905632T4 TR 201905632 T4 TR201905632 T4 TR 201905632T4 TR 2019/05632 T TR2019/05632 T TR 2019/05632T TR 201905632 T TR201905632 T TR 201905632T TR 201905632 T4 TR201905632 T4 TR 201905632T4
- Authority
- TR
- Turkey
- Prior art keywords
- tumor
- mesenchymal stem
- treatment
- stem cell
- conditioned media
- Prior art date
Links
- 239000003636 conditioned culture medium Substances 0.000 title abstract 4
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 210000002901 mesenchymal stem cell Anatomy 0.000 title abstract 2
- 230000003169 placental effect Effects 0.000 title abstract 2
- 102100023698 C-C motif chemokine 17 Human genes 0.000 abstract 1
- 101000978362 Homo sapiens C-C motif chemokine 17 Proteins 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 238000009630 liquid culture Methods 0.000 abstract 1
- 210000002826 placenta Anatomy 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2033—IL-5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2046—IL-7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2053—IL-8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2066—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2086—IL-13 to IL-16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/10—Protein-tyrosine kinases (2.7.10)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/27—Endoribonucleases producing 3'-phosphomonoesters (3.1.27)
- C12Y301/27008—Ribonuclease V (3.1.27.8)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Sıvı bir kültür ortamında, preeklamptik bir plasentadan plasental mezenkimal kök hücreler kültürlenerek elde edilebilen bir koşullu ortam (CM) açıklanmaktadır. Buluşun amacı olan koşullu ortam, en az IP-10 ve TARC proteinleri kapsamaktadır ve bir tümörün, tercihen bir epitelyal tümörün, terapötik tedavisinde kullanıma yönelik kullanılmaktadır.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000859A ITTO20120859A1 (it) | 2012-10-02 | 2012-10-02 | Nuova applicazione terapeutica di un mezzo condizionato da cellule staminali mesenchimali placentari |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201905632T4 true TR201905632T4 (tr) | 2019-05-21 |
Family
ID=47278467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2019/05632T TR201905632T4 (tr) | 2012-10-02 | 2013-10-02 | Bir tümörün tedavisinde kullanıma yönelik preeklamptik plasental mezenkimal kök hücre koşullu ortam. |
Country Status (11)
Country | Link |
---|---|
US (1) | US9943548B2 (tr) |
EP (1) | EP2903624B1 (tr) |
JP (1) | JP6306025B2 (tr) |
CN (2) | CN104822385B (tr) |
CA (1) | CA2886946C (tr) |
DK (1) | DK2903624T3 (tr) |
ES (1) | ES2720232T3 (tr) |
IT (1) | ITTO20120859A1 (tr) |
PL (1) | PL2903624T3 (tr) |
TR (1) | TR201905632T4 (tr) |
WO (1) | WO2014054004A1 (tr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016020572A1 (es) * | 2014-08-04 | 2016-02-11 | Universidad De Granada | MEDIO DE CULTIVO Y MÉTODO DE ENRIQUECIMIENTO Y MANTENIMIENTO DE CÉLULAS MADRE CANCERÍGENAS (CSCs) MEDIANTE EL USO DE DICHO MEDIO |
RU2644650C2 (ru) * | 2014-12-01 | 2018-02-13 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток и способ его получения |
JP6832349B2 (ja) * | 2015-06-03 | 2021-02-24 | エアラン セル テクノロジーズ, インコーポレイテッド | Il−2に基づく治療法および間葉系幹細胞に基づく治療法のためコンパニオン方法およびキット |
US11291689B2 (en) | 2015-06-03 | 2022-04-05 | Aelan Cell Technologies, Inc. | Methods and devices for the production and delivery of beneficial factors from adipose-derived stem cells |
WO2017123312A2 (en) * | 2015-09-02 | 2017-07-20 | Regeneration Worldwide Company, Inc. | Composition and methods of using umbilical cord lining stem cells |
RU2708329C2 (ru) * | 2016-05-31 | 2019-12-05 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток, композиции и способы применения |
JP2019214514A (ja) * | 2016-10-06 | 2019-12-19 | Aof株式会社 | 抗体産生力を上げる培養上清製剤 |
KR101865040B1 (ko) * | 2017-01-05 | 2018-06-11 | 가톨릭대학교 산학협력단 | 면역조절인자의 생성능이 강화된 중간엽 줄기세포의 용도 |
US20210260141A1 (en) * | 2018-07-18 | 2021-08-26 | Exostem Biotec Ltd. | Msc- and exosome-based immunotherapy |
US10758571B1 (en) * | 2019-04-09 | 2020-09-01 | Combangio, Inc. | Processes for making and using a mesenchymal stem cell derived secretome |
CN110025769A (zh) * | 2019-05-14 | 2019-07-19 | 美亚宜彬生物科技(北京)有限公司 | 干细胞和细胞因子的组合及其在改善***活力的用途 |
CN110904031A (zh) * | 2019-12-31 | 2020-03-24 | 福建省银丰干细胞工程有限公司 | 一种从人胎盘底蜕膜组织中分离母体来源间充质干细胞的方法 |
CN112315979A (zh) * | 2020-08-04 | 2021-02-05 | 源铭(上海)生物技术有限公司 | 药物组合物及其制备方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2564044T3 (es) * | 2003-06-27 | 2016-03-17 | DePuy Synthes Products, Inc. | Células posparto derivadas de tejido del cordón umbilical y métodos de preparación y uso de las mismas |
US20070087986A1 (en) * | 2004-01-26 | 2007-04-19 | Brett Premack | Compositions and methods for enhancing immunity by chemoattractant adjuvants |
WO2006069449A1 (en) * | 2004-12-29 | 2006-07-06 | The University Of British Columbia | Chemokine receptor-independent immunomodulatory and anti-proliferative activity |
US20060257359A1 (en) * | 2005-02-28 | 2006-11-16 | Cedric Francois | Modifying macrophage phenotype for treatment of disease |
US7993918B2 (en) * | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
NZ591293A (en) * | 2008-08-22 | 2012-10-26 | Anthrogenesis Corp | Methods and compositions for treatment of bone defects with osteogenic placental adherent cells (OPACs) |
ITTO20111183A1 (it) | 2011-12-21 | 2013-06-22 | Univ Degli Studi Torino | Mezzo condizionato ottenuto da cellule staminali mesenchimali placentari e suo uso nel trattamento terapeutico della preeclampsia |
-
2012
- 2012-10-02 IT IT000859A patent/ITTO20120859A1/it unknown
-
2013
- 2013-10-02 EP EP13792477.5A patent/EP2903624B1/en active Active
- 2013-10-02 CA CA2886946A patent/CA2886946C/en active Active
- 2013-10-02 CN CN201380062876.2A patent/CN104822385B/zh active Active
- 2013-10-02 TR TR2019/05632T patent/TR201905632T4/tr unknown
- 2013-10-02 WO PCT/IB2013/059064 patent/WO2014054004A1/en active Application Filing
- 2013-10-02 ES ES13792477T patent/ES2720232T3/es active Active
- 2013-10-02 DK DK13792477.5T patent/DK2903624T3/en active
- 2013-10-02 JP JP2015535152A patent/JP6306025B2/ja active Active
- 2013-10-02 CN CN201810895444.4A patent/CN108939051B/zh active Active
- 2013-10-02 US US14/432,722 patent/US9943548B2/en active Active
- 2013-10-02 PL PL13792477T patent/PL2903624T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
EP2903624A1 (en) | 2015-08-12 |
DK2903624T3 (en) | 2019-04-29 |
US9943548B2 (en) | 2018-04-17 |
US20150250823A1 (en) | 2015-09-10 |
JP2015532099A (ja) | 2015-11-09 |
ES2720232T3 (es) | 2019-07-18 |
WO2014054004A9 (en) | 2015-06-11 |
JP6306025B2 (ja) | 2018-04-04 |
ITTO20120859A1 (it) | 2014-04-03 |
CN108939051B (zh) | 2022-04-15 |
CA2886946A1 (en) | 2014-04-10 |
EP2903624B1 (en) | 2019-01-16 |
CN108939051A (zh) | 2018-12-07 |
PL2903624T3 (pl) | 2019-07-31 |
CN104822385B (zh) | 2019-10-01 |
CN104822385A (zh) | 2015-08-05 |
CA2886946C (en) | 2021-06-01 |
WO2014054004A1 (en) | 2014-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR201905632T4 (tr) | Bir tümörün tedavisinde kullanıma yönelik preeklamptik plasental mezenkimal kök hücre koşullu ortam. | |
TR201904270T4 (tr) | Tanımlı koşullar altında insan pluripotent kök hücrelerinin hematoendotelyal farklılaşması için yöntemler ve materyaller. | |
HRP20181989T1 (hr) | Sredstva za i postupci određivanja biološke aktivnosti neurotoksičnih polipeptida u stanicama | |
CY1121217T1 (el) | Μεθοδοι για συγκομιδη καλλιεργειων κυτταρου θηλαστικων | |
AR093446A1 (es) | Anticuerpos de antihemaglutinina y metodos de uso | |
GB2561496A (en) | Devices and methods for simulating a function of a liver tissue | |
EP3436570A4 (en) | MEDIUM, PROCEDURE, CELLS AND SECRETATED FACTORS FOR STEM CELL CULTURE AND THERAPY | |
EA201492183A1 (ru) | Клетки для получения рекомбинантной идуронат-2-сульфатазы | |
GB2562396A (en) | Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof | |
WO2014153115A3 (en) | Compositions and methods for reprogramming hematopoietic stem cell lineages | |
EA201590488A1 (ru) | Способы модификации клеток-хозяев | |
EP4219765A3 (en) | Prostate cancer prognosis using biomarkers | |
MX2020009704A (es) | Metodo para usar expresion genica para determinar la probabilidad de un desenlace clinico de cancer renal. | |
BR112014031424A2 (pt) | tratamento de células pluripotentes | |
MX2015011965A (es) | Metodos de creacion de bancos de celulas de alta densidad. | |
WO2013166338A3 (en) | Cell capture system and use thereof | |
HK1222198A1 (zh) | 用於提高幹細胞再生能力的培養基組合物及使用它的幹細胞培養方法 | |
MX2020009670A (es) | Metodos de cultivo por perfusion y usos de los mismos. | |
CL2012001143A1 (es) | Anticuerpo anti-fractalkina (anti-fkn); composicion farmaceutica que comprende dicho anticuerpo anti-fkn; acido nucleico; vector; celula huesped; uso del anticuerpo anti-fkn para tratar trastornos inflamatorios. | |
EA201492185A1 (ru) | Способ получения рекомбинантной идуронат-2-сульфатазы | |
EP2843041A4 (en) | CULTURE MEDIUM FOR STEM CELLS AND METHOD FOR CULTIVATING STEM CELLS USING THE SAME | |
BR112017028040A2 (pt) | métodos e aparelhos para condicionamento de populações de células para terapias celulares | |
BR112014020756A2 (pt) | co-uso de um inibidor da clusterina com um inibidor do egfr para tratar o câncer | |
MX2018014366A (es) | Interfaces de proteina. | |
WO2014155105A3 (en) | Assessment of risk of aneuploidy |